lymphoma
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Aged over 18 years; 2. Patients who are clinically diagnosed with lymphoma, have treatment indications after evaluation by a hematologist, and receive chemotherapy; 3. Those who obtained informed consent after having a detailed understanding of the purpose and protocol of this study.
Exclusion criteria
Exclusion criteria: 1. Those with a history of chemotherapy; 2. Those who have chemotherapy contraindications such as significant liver and kidney function damage after evaluation by a hematologist, and the above contraindications cannot be eliminated after active treatment and can tolerate chemotherapy; 3. There are contraindications to the special imaging examination used in this study, including internal metal implants, claustrophobic patients, pregnant women, allergic to drugs used in the examination process, contrast agents, and others who are not suitable for cardiac color Doppler ultrasound; 4. Known heart disease in the past, including myocarditis, various types of cardiomyopathy, coronary heart disease, high heart disease, severe valvular heart disease, significant arrhythmia, with or without heart failure, etc.; 5. Pregnant women; 6. Glaucoma patients; 7. Other researchers think that it is not suitable to participate in this researcher.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| creatine kinase isoenzyme;Troponin;high-sensitivity c-reactive protein;N-terminal precursor brain linatide;tumor suppressor factor 2;Overall longitudinal strain;left ventricular ejection fraction; | — |
Countries
China
Contacts
the First Affiliated Hospital of Chongqing Medical University